Omnipaque is a contrast dye used during X-ray and CT imaging to make organs, blood vessels, and other body structures visible on the scan. Its active ingredient, iohexol, contains iodine atoms that block X-rays as they pass through tissue. Areas where the dye collects appear bright white on the image, creating sharp contrast against surrounding structures that would otherwise look similar. It is a diagnostic tool only and has no therapeutic effect.
How Omnipaque Works
Iohexol is classified as a nonionic radiographic contrast agent. Nearly half its molecular weight (about 46%) comes from iodine, and iodine is exceptionally good at absorbing X-ray energy. When Omnipaque reaches a target area, the iodine atoms attenuate the X-ray beam in direct proportion to how much dye is present. The result is a real-time map of where the contrast has traveled, whether that’s inside a blood vessel, the spinal canal, or the digestive tract.
Because the concentration of dye in any given spot changes over time as the body absorbs and eliminates it, imaging teams can capture different phases of contrast enhancement by timing their scans carefully. A CT of the abdomen, for example, might be shot in an “arterial phase” seconds after injection and again in a “delayed phase” minutes later to highlight different tissues.
Common Diagnostic Uses
Omnipaque is approved for a wide range of imaging procedures across three broad delivery methods: into a vein, into the spinal canal, and by mouth or into body cavities.
Intravenous and Arterial Procedures
Injected into a vein or artery, Omnipaque is used for angiography (imaging blood vessels), urography (imaging the kidneys and urinary tract), and general CT enhancement. CT enhancement is probably its most common use: the dye highlights tumors, infections, and organ abnormalities that would be difficult to distinguish on an unenhanced scan. In children, it is approved for angiography and urography as well.
Spinal Imaging
When injected into the fluid-filled space around the spinal cord (an intrathecal injection), Omnipaque is used for myelography and CT myelography. These procedures visualize the spinal cord, nerve roots, and surrounding structures to diagnose conditions like herniated discs, spinal stenosis, or tumors. It is also used for CT cisternography, which images the fluid-filled spaces at the base of the brain. Both uses are approved in adults and children as young as two weeks old.
Oral and Body Cavity Procedures
Omnipaque can be swallowed to outline the gastrointestinal tract on X-ray or CT, which is useful when barium (the traditional GI contrast) isn’t safe, such as when a bowel perforation is suspected. It is also injected directly into joints for arthrography, into the uterus and fallopian tubes for hysterosalpingography (a fertility evaluation), and into the bile and pancreatic ducts during endoscopic procedures. GI tract studies are approved for adults, children, and even premature infants.
What to Expect During Administration
The delivery method depends entirely on the procedure. For a contrast-enhanced CT scan, the most common scenario, Omnipaque is injected into a vein in your arm through an IV line. Many people feel a warm, flushing sensation that spreads through the body within seconds and fades quickly. A metallic taste in the mouth is also common and temporary.
For spinal procedures, the injection goes into your lower back while you lie on an exam table. Intrathecal injections are administered slowly, over one to two minutes. If you need repeat spinal imaging, at least 48 hours should pass between sessions to allow the contrast to clear, though five to seven days is preferred when scheduling allows.
Side Effects and Risks
Most people tolerate Omnipaque well. Mild reactions like nausea, a warm feeling, or brief discomfort at the injection site are the most frequent complaints and typically resolve on their own within minutes. More notable reactions, including hives, itching, or mild swelling, occur in a small percentage of patients. Severe allergic-type reactions (difficulty breathing, significant swelling, or a sharp drop in blood pressure) are rare but possible, which is why imaging facilities keep emergency equipment on hand.
Spinal use carries its own set of risks. Seizures have been reported after intrathecal injection, particularly when higher-than-recommended doses were given. Certain medications that lower the seizure threshold, including some antidepressants, antipsychotics, and anti-nausea drugs, may increase this risk. Patients on these medications may be asked to pause them 48 hours before and 24 hours after the procedure. Using the wrong concentration of Omnipaque for spinal injection is a serious safety concern and can cause severe neurological complications, so only specific formulations are approved for intrathecal use.
Kidney Health and Contrast Dye
The kidneys filter Omnipaque out of the bloodstream, which means the dye adds temporary workload to these organs. In most people this is insignificant, but in those with already-reduced kidney function, contrast dye can cause a condition sometimes called contrast-induced nephropathy. This is defined as a rise in creatinine (a waste product the kidneys filter) of 25% or more above baseline, or an increase of 0.5 mg/dL, within 48 to 72 hours of receiving the contrast.
Pre-existing chronic kidney disease is the single biggest risk factor. Other factors that raise the likelihood include age over 75, diabetes, heart failure, low blood pressure, dehydration, and anemia. The volume of contrast used also matters: doses above 100 mL carry higher risk. For people with known kidney concerns, imaging teams typically check kidney function with a blood test beforehand and ensure the patient is well hydrated to help the body clear the dye efficiently.
Effects on Thyroid Function
Because Omnipaque contains a large amount of iodine, it can temporarily interfere with thyroid function tests and radioactive iodine treatments. Research in human patients has shown that iohexol can reduce radioiodine thyroid uptake by 44% to 80%, depending on how the thyroid is functioning at the time. The duration of this interference varies based on the amount of free iodide released and the individual’s thyroid status. If you are scheduled for thyroid testing or radioactive iodine therapy, your care team will need to know about any recent contrast dye exposure so they can adjust timing accordingly.
Available Concentrations
Omnipaque comes in several iodine concentrations to match the needs of different procedures. Lower concentrations are typically used for body cavity studies and spinal imaging, where sensitivity to the dye is higher. Higher concentrations, such as the 350 mg iodine/mL formulation commonly used in coronary CT angiography, provide denser contrast for vascular and enhanced CT imaging. The imaging team selects the appropriate concentration based on the procedure type, the body area being studied, and patient factors like body size.